Anna Lübking

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Mette Ilander, Ulla Olsson‐Strömberg, Heinrich Schlums et al. · Leukemia · 2016 · 247 citations · Full text

Medicine, Hematology, Immunology +14

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Henrik Hjorth‐Hansen, Jesper Stentoft, Johan Richter et al. · Leukemia · 2016 · 72 citations

Medicine, Oncology, Pharmacology +10

Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

Anna Lübking, Arta Dreimane, Fredrik Sandin et al. · Bone Marrow Transplantation · 2019 · 61 citations · Full text

Medicine, Hematology, Oncology +16

FLT3 ligand and not TSLP is the key regulator of IL-7–independent B-1 and B-2 B lymphopoiesis

Christina T. Jensen, Shabnam Kharazi, Charlotta Böiers et al. · Blood · 2008 · 52 citations · Full text

Life Sciences, Hematology, Immunology +13

Limited Efficacy of Ponatinib in Myeloproliferative Neoplasms Associated with FGFR1 Fusion Genes

Sebastian Kreil, Lionel Adès, Martin Bommer et al. · Blood · 2015 · 35 citations

Medicine, Genetics, Oncology +12